VivoSim Labs (VIVS) Research & Development (2011 - 2026)
VivoSim Labs' Research & Development came in at $1.13 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 13.1% from $1 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
VivoSim Labs (VIVS) Research & Development (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, VivoSim Labs reported Research & Development of $4.32 million, down 6.6% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $4.19 million, down 16.6% from FY2025.
- Research & Development has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 30.6% (FY2021 to FY2026).
- Going back by fiscal year, Research & Development was $5.03 million in FY2025 (-8.6%), $5.5 million in FY2024 (-38.1%), $8.89 million in FY2023 (+167.6%) and $3.32 million in FY2022 (+201.0%).
- The five-year range for quarterly Research & Development is $679,000 (fiscal Q2 2022) to $5.45 million (fiscal Q4 2023).
- Year-over-year, Research & Development increased in three of the last eight quarters, with an average decline of 6.0%.
- The fastest year-over-year change in Research & Development over five years came in fiscal Q4 2023 (growth of 380.1%), and the weakest in fiscal Q4 2024 (a decline of 80.5%).
- Business Quant data shows VIVS's Research & Development at $1.13 million (Q4 2026), $1.14 million (Q3 2026) and $923,000 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.17 Bn | 35.87 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.45 Bn | 15.51 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 14.37 Bn | 13.56 Bn | 363.37 Mn | - |
| 4 | Icon | 13.16 Bn | 10.27 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 2.12 Bn | 1.50 Bn | 139.20 Mn | - |
| 6 | Ginkgo Bioworks Holdings | 625.60 Mn | -136.48 Mn | 18.44 Mn | 46.21 Mn |
| 7 | Evotec SE | 506.10 Mn | -1.10 Bn | - | - |
| 8 | Champions Oncology | 65.60 Mn | 40.68 Mn | 7.70 Mn | 2.34 Mn |
| 9 | MindWalk Holdings | 61.22 Mn | 24.88 Mn | 1.61 Mn | 921,603.43 |
| 10 | VivoSim Labs | 832,550.47 | -16.89 Mn | - | 1.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 923,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 859,000.00 |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 984,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 5.45 Mn |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 926,000.00 |
| Sep 30, 2021 | 679,000.00 |
API Access
VivoSim Labs Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VIVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VIVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VIVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();